| Document |
Document Title |
|
WO/2024/080626A1 |
Disclosed are: a Bacillus licheniformis JWS22003 strain (accession number: KACC 92452P) for promoting fermentation of by-products, auxin production, and plant growth; a method for promoting fermentation of by-products and plant growth by...
|
|
WO/2024/077445A1 |
Provided are a 5'UTR element comprising a nucleotide sequence as shown in SEQ ID NO: 11 and the use thereof in the production of L-arginine. Further provided are a functional expression element containing the 5'UTR element and a promoter...
|
|
WO/2024/077428A1 |
Provided is an enzyme with D-amino acid synthesis activity. The enzyme has an amino acid sequence as shown in SEQ ID NO: 10. Compared with an original strain before mutation, the enzyme has a higher catalytic activity for D-amino acid sy...
|
|
WO/2023/086502A9 |
Described in several exemplary embodiments herein are serum replacement compositions, cell culture media containing said serum replacement compositions, and uses thereof.
|
|
WO/2024/079114A1 |
The invention relates to the field of recombinant production of proteins in host cells. In particular, the invention relates to processes for manufacturing recombinant proteins in host cells which processes reduce the misincorporation of...
|
|
WO/2024/074714A1 |
The present invention provides a method for increasing the growth efficiency in an anaerobic microbial fermentation of a microorganism capable of converting CO2, CO or a mixture thereof into at least one organic compound, the method comp...
|
|
WO/2024/076509A1 |
A process and system for producing a nutrient supplement from an anaerobic fermentation process comprising fermenting in a gaseous substrate with an acetogenic culture. The process comprises recovering an oxygenated hydrocarbon and incub...
|
|
WO/2024/074105A1 |
The present invention belongs to the field of biopharmaceuticals. Provided in the present invention are keratin YK93-4, a nucleic acid molecule encoding same, an expression vector containing the nucleic acid molecule, a host cell contain...
|
|
WO/2024/075597A1 |
Provided is a method for manufacturing a copolymer polyhydroxyalkanoic acid mixture by culturing a microorganism. The mixture contains: a fraction (I) which includes a copolymer polyhydroxyalkanoic acid having a 3-hydroxybutyric acid str...
|
|
WO/2024/077194A2 |
The invention relates to direct-fed microbials for use in improving the performance of an animal and improving the health of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus coagulans str...
|
|
WO/2024/077121A1 |
Oral care compositions that contain a particular mixture of mono-rhamnolipids and dirhamnolipids are disclosed. The compositions have antimicrobial efficacy against oral microbes, such as P. gingivalis, S. mutans, and C. rectus. Also dis...
|
|
WO/2024/075722A1 |
The present invention provides: a method for culturing adhesive cells using a microcarrier coated with a polymer that exhibits a lower critical temperature within a culture vessel, wherein the method is characterized by including the fol...
|
|
WO/2024/075997A1 |
The present invention provides a microalgae production system via a culture solution spraying method under an anhydrous cultivation condition, Haematococcus cultivated therethrough, and astaxanthin obtained by Haematococcus, wherein the ...
|
|
WO/2024/074540A2 |
The invention relates to a genetically engineered cell and compositions comprising said cell, wherein said cell is engineered to be especially sensitive towards two or more environmental factors, to enhance the biosafety profile of said ...
|
|
WO/2024/074102A1 |
The present invention pertains to the field of biopharmaceuticals and provides a keratin YK93-6, a nucleic acid molecule encoding same, an expression vector comprising the nucleic acid molecule, a host cell that contains the expression v...
|
|
WO/2024/074604A1 |
The present invention relates to compound of general formula (I): wherein the variables take the various meanings, pharmaceutical compositions containing them and their use in medicine, particularly in cancer such as Glioblastoma. The co...
|
|
WO/2024/074107A1 |
The present invention belongs to the field of biopharmaceuticals. Provided are a keratin YK93-2, a nucleic acid molecule encoding the same, an expression vector comprising the nucleic acid molecule, a host cell comprising the expression ...
|
|
WO/2024/074556A1 |
The present invention relates to a new B. subtilis strain with positive influence on Alzheimer's disease.
|
|
WO/2024/074111A1 |
The present invention pertains to the field of biopharmaceuticals and provides a keratin YK93-9, a nucleic acid molecule encoding same, an expression vector comprising the nucleic acid molecule, a host cell that contains the expression v...
|
|
WO/2024/076222A1 |
The present invention relates to an Aureobasidium pullulans AK-10 strain, a composition for reducing drought stress comprising the strain, a culture thereof, or an extract thereof, a method for preparing the composition, and a method for...
|
|
WO/2024/076723A1 |
Provided herein are methods to harvest EVs (such as increased yields of EVs) from bacterial cultures.
|
|
WO/2024/074110A1 |
The present invention relates to the field of biological pharmacy, provides keratin YK93-5, a nucleic acid molecule encoding same, an expression vector containing the nucleic acid molecule, a host cell containing the expression vector or...
|
|
WO/2024/075756A1 |
Provided is a method for producing a library containing gene-modified cells. This library is useful in the functional evaluation of a specific region of a genome and the introduction, etc., of various types of mutations (such as SNPs) to...
|
|
WO/2024/076937A2 |
Disclosed are methods of culturing a pigment producing fungus, including steps of inoculating a first liquid media with conidia of the fungus; performing a mycelium production culturing step comprising culturing the conidia in the first ...
|
|
WO/2024/073860A1 |
A virus-based active agent is mixed with trehalose and water and dried. The mixture may also contain one or more of pullulan and albumin. The mixture may be dried to a moisture content of 0.1-10%. The drying may be under vacuum sufficien...
|
|
WO/2024/075803A1 |
The present invention addresses the problem of providing: a method for testing a cranial nerve disease including schizophrenia, or a method for testing the sensitivity to a cranial nerve disease; and a reagent and a kit for use in the te...
|
|
WO/2024/075674A1 |
The purpose of the present technology is to provide: a protein that has a protocatechuic acid 5-position oxidizing activity and can efficiently generate gallic acid from protocatechuic acid; and a microbial strain that expresses said pro...
|
|
WO/2024/074104A1 |
The present invention belongs to the field of biopharmaceuticals. Provided in the present invention are keratin YK93-8, a nucleic acid molecule encoding same, an expression vector containing the nucleic acid molecule, a host cell contain...
|
|
WO/2024/077193A2 |
The invention relates to microbials for use in improving the health of a human and animals. More particularly, the invention relates to isolated Bacillus strains, and strains having all of the identifying characteristics of these strains...
|
|
WO/2024/075780A1 |
Provided is a method for stably mass culturing Dehalococcoides genus bacteria using a keg-like metal pressure-resistant culture vessel. This method for culturing Dehalococcoides genus bacteria uses a metal pressure-resistant culture ve...
|
|
WO/2024/076047A1 |
The present invention relates to: a Streptomyces lydicus JCK-6019 strain having excellent antifungal activity and, at the same time, being capable of inducing resistance in a treated plant; a composition for plant disease control compris...
|
|
WO/2024/077181A1 |
Provided are isolated strains of Lactobacillus reuteri, their use in methods of producing 3-hydroxypropanal (reuterin) and/or propenoic acid that involves culturing the isolated strain in a growth medium and a production medium, along wi...
|
|
WO/2024/076308A1 |
The present disclosure relates to a microbial consortium for plant growth and a method for preparing the microbial consortium The microbial consortium comprises at least two microbial strains, wherein each of the at least two microbial s...
|
|
WO/2024/071109A1 |
The purpose of the present invention is to simplify a cell culture device. The present invention relates to a cell culture device (100) for culturing cells, the cell culture device being equipped with: a culture tank (1) for pooling a cu...
|
|
WO/2024/066822A1 |
The present invention provides a method for producing γ-butyrolactone or 1,4-butanediol by fermentation. By means of a synthetic biology technique, Corynebacterium glutamicum is taken as a chassis, and an exogenous glutamate decarboxyla...
|
|
WO/2024/068640A1 |
A method for producing fungal spores, wherein the fungal spores are grown in a first liquid medium and then in a second liquid medium, the first liquid medium having a lower carbon content than the second liquid medium.
|
|
WO/2024/065008A1 |
The present invention relates to a method for harvesting microalgae, the method comprising (i) mixing one or more monomers, a photoinitiator, water and a deoxygenation system to form a mixture; (ii) exposing the mixture to UV light so as...
|
|
WO/2024/071397A1 |
The present invention provides an IL13RA2-targeting herpes simplex virus in which an anti-IL13RA2 antibody or an antigen-binding fragment thereof is presented on the viral surface. Also provided is an anti-IL13RA2 antibody or an antigen-...
|
|
WO/2024/071336A1 |
The present invention relates to a bacterial exopolysaccharide having a repeating structure comprising a series of repeating units represented by formula (I), and to the use of the bacterial exopolysaccharide for immunopotentiation. (In ...
|
|
WO/2024/071736A1 |
An aspect of the present invention relates to a pharmaceutical composition for the prevention or treatment of allergic diseases, containing dead cells of Streptococcus pyogenes or Streptococcal pyrogenic Exotoxin A (SpeA) protein. The de...
|
|
WO/2024/066819A1 |
Disclosed is a method for producing 3-hydroxypropionic acid and acrylic acid by means of fermentation. The present invention provides a recombinant Corynebacterium glutamicum. The aldehyde dehydrogenase gene ald of the microorganism is u...
|
|
WO/2024/067386A1 |
The present invention provides a culture medium and use thereof in water toxicity colorimetric detection. The culture medium comprises glucose, peptone, NaCl, a beef extract, and a ferric salt. The solubility of the ferric salt in water ...
|
|
WO/2024/073063A1 |
Described herein is a method of diagnosing Lyme disease in a subject. The method includes determining a glycosylation profile of a protein whose glycosylation profile is associated with Lyme disease in a subject, and comparing the glycos...
|
|
WO/2024/071279A1 |
Provided is a super-high-molecular gamma-polyglutamic acid having an average molecular weight of at least 20 million. Also provided is a Bacillus genus bacterium variant strain that can produce said super-high-molecular γ-PGA. Further p...
|
|
WO/2024/067747A1 |
The present invention provides a 5'-UTR sequence capable of improving the translation efficiency of a protein coding region, and a use thereof. The 5'-UTR sequence of the present invention can improve the translation efficiency of the pr...
|
|
WO/2024/066079A1 |
The present invention provides a bile acid metabolizing bacterium for preventing and treating an inflammatory bowel disease and use thereof. The present invention provides a bacterium which comprises any one, two or three of the followin...
|
|
WO/2024/067086A1 |
Provided is a Bacillus licheniformis cell capable of being stably and repeatedly used for conversion and synthesis of D-allulose, which belongs to the field of biotechnology. D-allulose is a functional sugar with a high health value and ...
|
|
WO/2024/067591A1 |
Provided are a Collinsella aerofaciens capable of regulating an autoimmune response and use thereof in the field of immunotherapy of inflammatory bowel disease. By enhancing the differentiation of Treg cells, the Collinsella aerofaciens ...
|
|
WO/2024/070185A1 |
[Problem] To provide a biomarker which is usable for determining the onset risk of acne. [Solution] One aspect of the present invention provides a biomarker which is usable for determining the onset risk of acne. The biomarker is type II...
|
|
WO/2024/073719A2 |
Bacillus strain compositions and methods for reducing growth of one or more mastitis-causing organisms and/or reducing a symptom, sign, or occurrence of mastitis in animals are provided. The Bacillus strain composition can comprise a bac...
|
